GSK – GlaxoSmithKline plc
Float Short %
0.55
Margin Of Safety %
30
Put/Call OI Ratio
0.5
EPS Next Q Diff
-0.57
EPS Last/This Y
EPS This/Next Y
0.45
Price
40.85
Target Price
43.7
Analyst Recom
3
Performance Q
-3.91
Relative Volume
0.98
Beta
0.52
Ticker: GSK
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | GSK | 39.33 | 0.44 | 0.39 | 135098 |
| 2025-08-18 | GSK | 39.08 | 0.40 | 0.54 | 75618 |
| 2025-08-19 | GSK | 39.62 | 0.41 | 0.19 | 77996 |
| 2025-08-20 | GSK | 40.08 | 0.40 | 0.53 | 79311 |
| 2025-08-21 | GSK | 40.09 | 0.41 | 0.37 | 85134 |
| 2025-08-22 | GSK | 40.19 | 0.41 | 0.25 | 88936 |
| 2025-08-25 | GSK | 39.63 | 0.41 | 0.87 | 88410 |
| 2025-08-26 | GSK | 39.83 | 0.41 | 0.91 | 88805 |
| 2025-08-27 | GSK | 39.94 | 0.44 | 15.22 | 94224 |
| 2025-08-28 | GSK | 39.44 | 0.54 | 1.86 | 101223 |
| 2025-08-29 | GSK | 39.67 | 0.56 | 15.40 | 103102 |
| 2025-09-02 | GSK | 38.96 | 0.66 | 1.62 | 99003 |
| 2025-09-03 | GSK | 39.36 | 0.65 | 0.59 | 99267 |
| 2025-09-04 | GSK | 39.61 | 0.64 | 0.17 | 101107 |
| 2025-09-05 | GSK | 40.49 | 0.61 | 0.15 | 104038 |
| 2025-09-08 | GSK | 40.06 | 0.50 | 1.11 | 102645 |
| 2025-09-09 | GSK | 40.79 | 0.51 | 0.19 | 103334 |
| 2025-09-10 | GSK | 40.5 | 0.50 | 0.62 | 104110 |
| 2025-09-11 | GSK | 41.49 | 0.50 | 0.39 | 104372 |
| 2025-09-12 | GSK | 40.85 | 0.50 | 0.80 | 105774 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | GSK | 39.33 | -9.6 | 5598.1 | 4.11 |
| 2025-08-18 | GSK | 39.08 | -9.6 | 5504.5 | 4.11 |
| 2025-08-19 | GSK | 39.62 | -9.6 | 5545.7 | 4.13 |
| 2025-08-20 | GSK | 40.08 | -9.6 | 5799.0 | 4.13 |
| 2025-08-21 | GSK | 40.09 | -9.6 | 5581.8 | 4.13 |
| 2025-08-22 | GSK | 40.19 | -9.6 | 5517.9 | 4.13 |
| 2025-08-25 | GSK | 39.63 | -9.6 | 5465.1 | 4.13 |
| 2025-08-26 | GSK | 39.83 | -9.6 | 5402.7 | 4.13 |
| 2025-08-27 | GSK | 39.94 | -9.6 | 5500.2 | 4.13 |
| 2025-08-28 | GSK | 39.44 | -9.6 | 5352.9 | 4.13 |
| 2025-08-29 | GSK | 39.67 | -9.6 | 5532.9 | 4.13 |
| 2025-09-02 | GSK | 38.96 | -9.6 | 4843.5 | 4.13 |
| 2025-09-03 | GSK | 39.37 | -9.6 | 5774.3 | 4.13 |
| 2025-09-04 | GSK | 39.60 | -9.6 | 5728.5 | 4.13 |
| 2025-09-05 | GSK | 40.50 | -9.6 | 5883.3 | 4.13 |
| 2025-09-08 | GSK | 40.05 | -9.4 | 5488.0 | 4.14 |
| 2025-09-09 | GSK | 40.79 | -9.4 | 5989.9 | 4.14 |
| 2025-09-10 | GSK | 40.49 | -9.4 | 5444.5 | 4.14 |
| 2025-09-11 | GSK | 41.48 | -9.4 | 6030.2 | 4.14 |
| 2025-09-12 | GSK | 40.85 | -9.4 | 5617.9 | 4.14 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | GSK | 0 | -5.84 | 0.62 |
| 2025-08-18 | GSK | 0 | -5.39 | 0.62 |
| 2025-08-19 | GSK | 0 | -5.39 | 0.62 |
| 2025-08-20 | GSK | 0 | -5.39 | 0.62 |
| 2025-08-21 | GSK | 0 | -5.39 | 0.62 |
| 2025-08-22 | GSK | 0 | -5.39 | 0.62 |
| 2025-08-25 | GSK | 0 | -1.81 | 0.62 |
| 2025-08-26 | GSK | 0 | -1.81 | 0.62 |
| 2025-08-27 | GSK | 0 | -1.81 | 0.56 |
| 2025-08-28 | GSK | 0 | -1.81 | 0.56 |
| 2025-08-29 | GSK | 0 | -1.81 | 0.56 |
| 2025-09-02 | GSK | 0 | -1.74 | 0.56 |
| 2025-09-03 | GSK | 0 | -1.74 | 0.56 |
| 2025-09-04 | GSK | 0 | -1.74 | 0.56 |
| 2025-09-05 | GSK | 0 | -1.74 | 0.56 |
| 2025-09-08 | GSK | 0 | -1.78 | 0.56 |
| 2025-09-09 | GSK | 0 | -1.78 | 0.56 |
| 2025-09-10 | GSK | 0 | -1.78 | 0.56 |
| 2025-09-11 | GSK | 0 | -1.78 | 0.55 |
| 2025-09-12 | GSK | 0 | -1.78 | 0.55 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.23
Avg. EPS Est. Current Quarter
1.17
Avg. EPS Est. Next Quarter
0.66
Insider Transactions
Institutional Transactions
-1.78
Beta
0.52
Average Sales Estimate Current Quarter
8208
Average Sales Estimate Next Quarter
8237
Fair Value
52.9
Quality Score
88
Growth Score
68
Sentiment Score
95
Actual DrawDown %
15.4
Max Drawdown 5-Year %
-39.3
Target Price
43.7
P/E
19.03
Forward P/E
8.41
PEG
2.04
P/S
2.01
P/B
4.08
P/Free Cash Flow
10.63
EPS
2.15
Average EPS Est. Cur. Y
4.14
EPS Next Y. (Est.)
4.58
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
10.81
Relative Volume
0.98
Return on Equity vs Sector %
-1.7
Return on Equity vs Industry %
-10.3
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.12
EBIT Estimation
5617.9
GSK plcSector: Healthcare
Industry: Drug Manufacturers - General
Employees: 68629
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.
stock quote shares GSK – GlaxoSmithKline plc Stock Price stock today
news today GSK – GlaxoSmithKline plc stock forecast ,stock prediction 2023 2024 2025
marketwatch GSK – GlaxoSmithKline plc yahoo finance google finance
stock history GSK – GlaxoSmithKline plc invest stock market
stock prices GSK premarket after hours
ticker GSK fair value insiders trading